MYLAN PHARMACEUTICALS INC. 401(K) DEFINED CONTRIBUTION PLAN
ERISA Form 5500 plan record drawn from DOL EBSA — verify with linked source filings below.
MYLAN PHARMACEUTICALS INC.
This 401(k) plan holds $48M in total assets and serves 251 participants as of 2022. It is sponsored by MYLAN PHARMACEUTICALS INC. in Pennsylvania. The plan reported a net loss of $31M for the year.
What the Filing Says About MYLAN PHARMACEUTICALS INC. 401(K) DEFINED CONTRIBUTION PLAN
MYLAN PHARMACEUTICALS INC. 401(K) DEFINED CONTRIBUTION PLAN is a 401(k) retirement plan sponsored by MYLAN PHARMACEUTICALS INC., headquartered in Pennsylvania. As of the 2022 Form 5500 filing, the plan reports $48M in total end-of-year assets and covers 251 participants across the Manufacturing industry. The sponsor's EIN on file with the U.S. Department of Labor is 550455423, and the plan has been effective since 1985-09-23. Its filing status is currently FILING RECEIVED.
Year over year, total assets moved from $79M at the beginning of 2022 to $48M at year-end — a decline of 38.9%. Net assets (after liabilities) closed the year at $48M, with reported net income of $-30,801,331 driven by investment returns, contributions received, and benefit payments during the period. These figures reflect what the plan administrator certified on Schedule H or Schedule I of the Form 5500 annual return and can be compared against 2 prior plan-year filings from the same sponsor shown below.
Asset totals and participant counts reflect a single plan year snapshot and can change materially with market conditions, plan mergers, or workforce changes. Fields such as "net income" include both realized investment performance and contribution/distribution flows — a single-year figure does not by itself indicate plan health or participant outcomes. This page summarizes public DOL disclosures for research and educational purposes only and is not retirement, tax, legal, or financial advice. Before making decisions about your own retirement benefits or evaluating an employer's plan, verify the underlying filing directly via the DOL EFAST2 system and consult a qualified professional.
Financial Summary (2023)
| Total Assets (Beginning of Year) | $79M |
| Total Assets (End of Year) | $48M |
| Net Assets (End of Year) | $48M |
| Net Income | $-30,801,331 |
| Plan Type | 401(k) |
| Employer EIN | 550455423 |
| Plan Effective Date | 1985-09-23 |
| Filing Status | FILING RECEIVED |
Sponsor Plan History (MYLAN PHARMACEUTICALS INC.)
| Year | Plans | Participants | Total Assets |
|---|---|---|---|
| 2022 | 1 | 251 | $48M |
| 2023 | 1 | 212 | $44M |
| 2024 | 1 | 82 | $42M |
Nearby 401(k) Plans in Pennsylvania
Peer 401(k) plans — same state, same plan type — ranked by total assets.
- COMCAST CORPORATION RETIREMENT - INVESTMENT PLAN $17.4B · 93,136
- CIGNA 401(K) PLAN $13.0B · 66,760
- THE VANGUARD RETIREMENT AND SAVINGS PLAN $9.8B · 18,200
- THE BANK OF NEW YORK MELLON CORPORATION 401(K) SAVINGS PLAN $9.0B · 25,184
- GSK 401(K) PLAN $8.1B · 11,837
Related Data
Guides
Related Data on Other Portals
Frequently Asked Questions
How much money is in the MYLAN PHARMACEUTICALS INC. 401(K) DEFINED CONTRIBUTION PLAN? ▼
What type of plan is MYLAN PHARMACEUTICALS INC. 401(K) DEFINED CONTRIBUTION PLAN? ▼
Who sponsors the MYLAN PHARMACEUTICALS INC. 401(K) DEFINED CONTRIBUTION PLAN? ▼
How did MYLAN PHARMACEUTICALS INC. 401(K) DEFINED CONTRIBUTION PLAN perform in 2022? ▼
Where can I find official filings for MYLAN PHARMACEUTICALS INC. 401(K) DEFINED CONTRIBUTION PLAN? ▼
How does MYLAN PHARMACEUTICALS INC. 401(K) DEFINED CONTRIBUTION PLAN compare to other plans? ▼
Explore PlainRetire
Source: U.S. Department of Labor, Employee Benefits Security Administration (EBSA), Form 5500 public disclosure dataset. Plan year 2022.
Source: DOL EFAST2 filing system (efast.dol.gov) — original filing retrieval by EIN 550455423.
Reference: IRS Publication 560 — Retirement Plans for Small Business, contribution-limit rules.
Reference: IRS Publication 590-B — Distributions from IRAs, RMD rules under SECURE Act 2.0.
Read our methodology — how this data is sourced, computed, and verified.